Month: January 2021

ARTEA, MAITRE D’OUVRAGE ET CO-INVESTISSEUR POUR LA RECONVERSION DE  « L’EX-COUVENT DE SANT’ORSOLA »,LIEU EMBLEMATIQUE ET CLASSÉ  DE LA VILLE DE FLORENCE (Italie)Ce mardi 19 janvier 2021 à 12h, M. Dario NARDELLA, maire de Florence, et M. Philippe BAUDRY, DG d’ARTEA, présenteront lors d’une conférence de presse virtuelle le projet de reconversion et transformation de Sant’Orsola.Un projet de restructuration architecturale imaginé comme un lieu de vie conjuguant patrimoine et cultureDans le cadre d’une consultation de la Ville Métropolitaine de Florence, le Groupe ARTEA a été retenu pour réhabiliter le site de Sant’Orsola avec la signature d’un contrat de concession lui octroyant la jouissance du site pendant 50 ans.Le complexe de Sant’Orsola est un ancien couvent du XIVème siècle construit autour de 3 grandes cours, d’une surface totale...

I henhold til tidligere offentliggjort meddelelse udbetales foreløbige udlodninger som følger:Det kan oplyses, at sidste handelsdag for andele inkl. foreløbig udlodning for 2020 er mandag, den 25. januar 2021 og første handelsdag for andele ex foreløbig udlodning er herefter tirsdag, den 26. januar 2021. Der forventes udbetaling til investorerne torsdag, den 28. januar 2021.Eventuelle henvendelser vedrørende denne meddelelse kan rettes til direktør Tage Fabrin-Brasted, tlf. 44 55 91 60.Med venlig hilsenInvesteringsforeningen Multi Manager InvestTage Fabrin-Brasted, direktørVedhæftet filFB_MMI_udlodning_2020_19_01_2021

I henhold til tidligere offentliggjort meddelelse udbetales foreløbige udlodninger som følger:Det kan oplyses, at sidste handelsdag for andele inkl. foreløbig udlodning for 2020 er mandag, den 25. januar 2021 og første handelsdag for andele ex foreløbig udlodning er herefter tirsdag, den 26. januar 2021. Der forventes udbetaling til investorerne torsdag, den 28. januar 2021.Eventuelle henvendelser vedrørende denne meddelelse kan rettes til direktør Tage Fabrin-Brasted,tlf. 44 55 91 60.Med venlig hilsenInvesteringsforeningen InvestinTage Fabrin-Brasted, direktørVedhæftet filFB_Investin_udlodning_2020_19_01_2021

SINGAPORE, Jan. 18, 2021 (GLOBE NEWSWIRE) — Triterras Inc. (Nasdaq: TRIT, TRITW), a leading fintech company for trade and trade finance, has authorized a share repurchase program of up to $50 million and provided updates on other recent events.$50 Million Share Repurchase ProgramTriterras’ recent share price has created an attractive opportunity for the company to institute a stock repurchase program. The Board of Directors has approved a share repurchase of up to $50 million of the Company’s common stock in open market or privately negotiated transactions, which may or may not be conducted through 10b5-1 plans.Triterras Chairman and CEO Srinivas Koneru Open Market Share PurchasesOn December 21, 2020, Chairman and CEO Srinivas Koneru announced his intention to purchase Triterras’ shares in the open market. Thus far, purchases have...

GARDEN CITY, NY, Jan. 18, 2021 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today the pricing of an underwritten public offering of 3,000,000 shares of common stock at an offering price of $12.50 per share, for gross proceeds of $37,500,000. In addition, ProPhase has granted the underwriters a 30-day option to purchase up to an additional 450,000 shares to cover over-allotments, if any. All of the shares are being offered by ProPhase.The offering is expected to close on January 21, 2021, subject to the satisfaction of customary closing conditions. ProPhase intends to use the net proceeds from the offering for working capital and other general corporate purposes.ThinkEquity, a division of Fordham Financial Management, Inc., is acting as sole book-running manager...

MEXICO CITY, Jan. 18, 2021 (GLOBE NEWSWIRE) — Grupo TMM, S.A.B. (OTC: GTMAY and BMV: TMM A; “TMM” or the “Company”), announced that Ms. Vanessa Serrano Cuevas obtained shares of the Company by donation, free of charge due to kinship by consanguinity, and consequently became a holder of 12% of the total outstanding shares.Regarding this acquisition, Mr. José F. Serrano Segovia, Chairman of the Board, commented, “It is a privilege to welcome Ms. Serrano Cuevas as a shareholder and as she assumes our shared commitment to the growth and development of Grupo TMM.”About Grupo TMMHeadquartered in Mexico City, Grupo TMM is a Mexican Maritime-management transportation and logistics Company. Through its branch offices and network of subsidiary companies, Grupo TMM provides a dynamic combination of Maritime services port management and logistics....

COVID-19 Host Genome Structural Variant (SV) Consortium used Saphyr to identify SVs in severe COVID-19 patients that affect genes involved in immunity, airway mucous, and viral replicationSVs found by several investigators point to a central role for disease severity of the interferon response pathwayConsortium has added investigators from Augusta University, Boston Children’s Hospital, New York Genome Center, Radboud University, Rockefeller University, UC San Diego, Virginia Commonwealth University, and two dozen other institutes from around the worldSAN DIEGO, Jan. 18, 2021 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) announced that the last day of its five-day Next-Generation Cytogenomics Symposium featured presentations by members of the COVID-19 Host Genome Structural Variant (SV) Consortium using the Saphyr® system...

This new maintenance service contract for 280 cars will be completely delivered within one year and further illustrates BST’s full capacityIn the last two years, BST has provided maintenance work for more than 1,200 high-speed train cars and has delivered the service with high qualityBERLIN, Jan. 19, 2021 (GLOBE NEWSWIRE) —Note to editors: To view the photo associated with this press release, please visit the following link: https://www.globenewswire.com/NewsRoom/AttachmentNg/f5a88f67-b910-4288-921e-46374ade6f37 Global mobility solution provider Bombardier Transportation announced today that its Chinese joint venture, Bombardier Sifang (Qingdao) Transportation Ltd. (BST), has been awarded a contract with China State Railway Group Co., Ltd. (CHINA RAILWAY) to provide maintenance service for 280 high-speed train cars (32 trains),...

LA JOLLA, Calif., Jan. 18, 2021 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Allowance from the Japan Patent Office for a pending patent application which covers the combination of MN-166 (ibudilast) and riluzole for the treatment of amyotrophic lateral sclerosis (ALS).Once issued, the patent maturing from this allowed patent application is expected to expire no earlier than November 2035. The allowed claims cover the combination of MN-166 (ibudilast) and riluzole for alleviating the negative effects of ALS, treating a patient diagnosed with ALS, and slowing progression of disease in a patient diagnosed with ALS.   The allowed claims cover a wide...